Royalty Pharma Sub-Manager, Llc Portfolio Stock Holdings

According to the SEC 13F filed on August 21, 2026, Royalty Pharma Sub-Manager, Llc disclosed 3 stock positions valued at approximately $241.92M as of quarter-end June 30, 2026. The largest holdings include CYTOKINETICS, INC, ZENAS BIOPHARMA, INC., and KAILERA THERAPEUTICS.

Report Period: June 30, 2026
No. of Stocks: 3
Portfolio Value: $241.92M

Holdings by Sector

Royalty Pharma Sub-Manager, Llc Portfolio Holdings in Q2 2026

Company	Symbol	Sector	Portfolio %	Shares	Change (Shares)	Change %	Value
CYTOKINETICS, INC	CYTK	Healthcare	34.52%	980,392	-	-	$83,519,594
ZENAS BIOPHARMA, INC.	ZBIO	Other	25.05%	2,388,150	-	-	$60,611,247
KAILERA THERAPEUTICS	KLRA	Other	22.36%	2,455,357	+2,455,357	+100.00%	$54,091,515

Showing 3 of 3 holdings in the latest reporting period.